{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:57:27Z","timestamp":1795089447136,"version":"4.10.2"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012964","name":"Minist\u00e8re de l&apos;Enseignement Sup\u00e9rieur et de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012964","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Systemic sclerosis (SSc) is an autoimmune disorder characterized by vascular damage, excessive fibrosis and abnormal T cells immune-regulation. CD146 is an adhesion molecule essentially expressed in the vascular system, but also on TH17 lymphocytes. In view of the recently described role of CD146 in SSc, we hypothesized an involvement of CD146 positive TH17 cells in this disease. Compared to healthy controls, we showed that both soluble form of CD146 (sCD146), and IL17A levels were increased in patients with SSc with a positive correlation between both factors. A significant increase in TH17 cells attested by an increase of ROR\u03b3T, IL17A mRNA and CD4+ IL17A+ cell was observed in patients with SSc. Interestingly, the percentage of TH17 cells expressing CD146 was higher in patients with SSc and inversely correlated with pulmonary fibrosis. <jats:italic>In vitro<\/jats:italic> experiments showed an augmentation of the percentage of TH17 cells expressing CD146 after cell treatment with sCD146, suggesting that, in patients the increase of this sub-population could be the consequence of the sCD146 increase in serum. In conclusion, TH17 cells expressing CD146 could represent a new component of the adaptive immune response, opening the way for the generation of new tools for the management of SSc.<\/jats:p>","DOI":"10.1038\/s41598-019-54132-y","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T11:02:46Z","timestamp":1574852566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["TH17 cells\u00a0expressing CD146 are significantly increased in patients with Systemic sclerosis"],"prefix":"10.1038","volume":"9","author":[{"given":"Amira","family":"Gabsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Heim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Dlala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Gati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifa","family":"Sakhri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Abidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Amri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilel","family":"Neili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie S.","family":"Leroyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandrine","family":"Bertaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Smiti Khanfir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Habib","family":"Houman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Granel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Blot-Chabaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Bardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Marrakchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,27]]},"reference":[{"key":"54132_CR1","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen, F. et al. 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative: ACR\/EULAR Classification Criteria for SSc. Arthritis & Rheumatism 65, 2737\u20132747 (2013).","journal-title":"Arthritis & Rheumatism"},{"key":"54132_CR2","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00296-017-3722-5","volume":"37","author":"W Zhao","year":"2017","unstructured":"Zhao, W. et al. The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms. Rheumatol Int 37, 1303\u20131310 (2017).","journal-title":"Rheumatol Int"},{"key":"54132_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1165\/rcmb.2016-0192OC","volume":"58","author":"H Chu","year":"2018","unstructured":"Chu, H. et al. Sirtuin1 Protects against Systemic Sclerosis\u2013related Pulmonary Fibrosis by Decreasing Proinflammatory and Profibrotic Processes. Am J Respir Cell Mol Biol 58, 28\u201339 (2018).","journal-title":"Am J Respir Cell Mol Biol"},{"key":"54132_CR4","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.jaci.2017.04.046","volume":"140","author":"E Kaspi","year":"2017","unstructured":"Kaspi, E. et al. Identification of CD146 as a novel molecular actor involved in systemic sclerosis. Journal of Allergy and Clinical Immunology 140, 1448\u20131451.e6 (2017).","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"54132_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0014-5793(97)01455-5","volume":"421","author":"N Bardin","year":"1998","unstructured":"Bardin, N., Franc\u00e8s, V., Combes, V., Sampol, J. & Dignat-George, F. CD146: biosynthesis and production of a soluble form in human cultured endothelial cells. FEBS Letters 421, 12\u201314 (1998).","journal-title":"FEBS Letters"},{"key":"54132_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1399-0039.1996.tb02666.x","volume":"48","author":"N Bardin","year":"1996","unstructured":"Bardin, N. et al. S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen. Tissue Antigens 48, 531\u2013539 (1996).","journal-title":"Tissue Antigens"},{"key":"54132_CR7","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1182\/blood.V98.13.3677","volume":"98","author":"N Bardin","year":"2001","unstructured":"Bardin, N. Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood 98, 3677\u20133684 (2001).","journal-title":"Blood"},{"key":"54132_CR8","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1161\/ATVBAHA.108.183251","volume":"29","author":"N Bardin","year":"2009","unstructured":"Bardin, N. et al. CD146 and its Soluble Form Regulate Monocyte Transendothelial Migration. ATVB 29, 746\u2013753 (2009).","journal-title":"ATVB"},{"key":"54132_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1161\/CIRCRESAHA.109.213827","volume":"107","author":"A Kebir","year":"2010","unstructured":"Kebir, A. et al. CD146 Short Isoform Increases the Proangiogenic Potential of Endothelial Progenitor Cells In Vitro and In Vivo. Circulation Research 107, 66\u201375 (2010).","journal-title":"Circulation Research"},{"key":"54132_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/01.MIB.0000194181.46930.88","volume":"12","author":"N Bardin","year":"2006","unstructured":"Bardin, N. et al. Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease. Inflammatory Bowel Diseases 12, 16\u201321 (2006).","journal-title":"Inflammatory Bowel Diseases"},{"key":"54132_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10067-016-3434-3","volume":"36","author":"T Ito","year":"2017","unstructured":"Ito, T. et al. Elevated serum levels of soluble CD146 in patients with systemic sclerosis. Clin Rheumatol 36, 119\u2013124 (2017).","journal-title":"Clin Rheumatol"},{"key":"54132_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1166\/jbn.2010.1136","volume":"6","author":"H Zheng","year":"2010","unstructured":"Zheng, H., Chen, G., DeLouise, L. A. & Lou, Z. Detection of the Cancer Marker CD146 Expression in Melanoma Cells with Semiconductor Quantum Dot Label. j biomed nanotechnol 6, 303\u2013311 (2010).","journal-title":"j biomed nanotechnol"},{"key":"54132_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10456-012-9317-6","volume":"16","author":"E Kaspi","year":"2013","unstructured":"Kaspi, E. et al. Identification of soluble CD146 as a regulator of trophoblast migration: potential role in placental vascular development. Angiogenesis 16, 329\u2013342 (2013).","journal-title":"Angiogenesis"},{"key":"54132_CR14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/cei.12434","volume":"179","author":"C Wu","year":"2015","unstructured":"Wu, C., Goodall, J. C., Busch, R. & Gaston, J. S. H. Relationship of CD146 expression to secretion of interleukin (IL)-17, IL-22 and interferon-\u03b3 by CD4+ T cells in patients with inflammatory arthritis: Cytokine secretion by CD146+ CD4+ T cells. Clin Exp Immunol 179, 378\u2013391 (2015).","journal-title":"Clin Exp Immunol"},{"key":"54132_CR15","doi-asserted-by":"publisher","first-page":"e0181868","DOI":"10.1371\/journal.pone.0181868","volume":"12","author":"G Castro","year":"2017","unstructured":"Castro, G. et al. ROR\u03b3t and ROR\u03b1 signature genes in human TH17 cells. PLoS One 12, e0181868 (2017).","journal-title":"PLoS One"},{"key":"54132_CR16","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cyto.2013.07.022","volume":"64","author":"C Gu","year":"2013","unstructured":"Gu, C., Wu, L. & Li, X. IL-17 family: Cytokines, receptors and signaling. Cytokine 64, 477\u2013485 (2013).","journal-title":"Cytokine"},{"key":"54132_CR17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1515\/rjim-2017-0027","volume":"55","author":"P B\u0103l\u0103nescu","year":"2017","unstructured":"B\u0103l\u0103nescu, P., B\u0103l\u0103nescu, E. & B\u0103l\u0103nescu, A. IL-17 and TH17 cells in systemic sclerosis: a comprehensive review. Romanian Journal of Internal Medicine 55, 198\u2013204 (2017).","journal-title":"Romanian Journal of Internal Medicine"},{"key":"54132_CR18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.it.2017.01.006","volume":"38","author":"N Amatya","year":"2017","unstructured":"Amatya, N., Garg, A. V. & Gaffen, S. L. IL-17 Signaling: The Yin and the Yang. Trends in Immunology 38, 310\u2013322 (2017).","journal-title":"Trends in Immunology"},{"key":"54132_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.humimm.2014.12.008","volume":"76","author":"Y Zhou","year":"2015","unstructured":"Zhou, Y. et al. The elevated expression of TH17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis. Human Immunology 76, 22\u201329 (2015).","journal-title":"Human Immunology"},{"key":"54132_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/986789","volume":"2013","author":"SK Bedoya","year":"2013","unstructured":"Bedoya, S. K., Lam, B., Lau, K. & Larkin, J. TH17 Cells in Immunity and Autoimmunity. Clinical and Developmental Immunology 2013, 1\u201316 (2013).","journal-title":"Clinical and Developmental Immunology"},{"key":"54132_CR21","doi-asserted-by":"publisher","first-page":"R166","DOI":"10.1186\/ar3486","volume":"13","author":"M-E Truchetet","year":"2011","unstructured":"Truchetet, M.-E., Brembilla, N. C., Montanari, E., Allanore, Y. & Chizzolini, C. Increased frequency of circulating Th22 in addition to TH17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease. Arthritis Res Ther 13, R166 (2011).","journal-title":"Arthritis Res Ther"},{"key":"54132_CR22","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1160\/TH02-11-0285","volume":"90","author":"N Bardin","year":"2003","unstructured":"Bardin, N. et al. Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alteration. Thromb Haemost 90, 915\u2013920 (2003).","journal-title":"Thromb Haemost"},{"key":"54132_CR23","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1002\/eji.200838469","volume":"38","author":"N Despoix","year":"2008","unstructured":"Despoix, N. et al. Mouse CD146\/MCAM is a marker of natural killer cell maturation. Eur. J. Immunol. 38, 2855\u20132864 (2008).","journal-title":"Eur. J. Immunol."},{"key":"54132_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jaut.2011.09.003","volume":"37","author":"PK Dagur","year":"2011","unstructured":"Dagur, P. K. et al. MCAM-expressing CD4+ T cells in peripheral blood secrete IL-17A and are significantly elevated in inflammatory autoimmune diseases. Journal of Autoimmunity 37, 319\u2013327 (2011).","journal-title":"Journal of Autoimmunity"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54132-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54132-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54132-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T16:28:16Z","timestamp":1671294496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54132-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,27]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["54132"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-54132-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,27]]},"assertion":[{"value":"28 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17721"}}